Ustekinumab Therapeutic Drug Monitoring—Impact on Clinical Practice: A Multicenter Cross-Sectional Observational Trial
Waqqas Afif, Brian Bressler(University of British Columbia), Bernie D. Sattin, Cynthia H. Seow(University of Calgary), Yanli Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Long-Long Gao(Janssen (United States)), Reena Khanna(Western University), Dorota Dajnowiec(Edwards Lifesciences (United States)), Kinda Karra(Merck Canada Inc. (Canada)), Martin Williamson
Cited by 13
Related Papers
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
|New England Journal of Medicine|2013|2.7k
Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease
|New England Journal of Medicine|2016|1.8k
Rates of New or Missed Colorectal Cancers After Colonoscopy and Their Risk Factors: A Population-Based Analysis
|Gastroenterology|2007|627
The Toronto Consensus Statements for the Management of Inflammatory Bowel Disease in Pregnancy
|Gastroenterology|2015|478